Company Filing History:
Years Active: 2012-2018
Title: John W Martens: Innovator in Cancer Treatment Prediction
Introduction
John W Martens is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of cancer treatment, particularly in predicting outcomes for patients undergoing anthracycline treatment. With a total of 3 patents, his work has the potential to impact patient care and treatment strategies.
Latest Patents
One of his latest patents is focused on "Markers for the prediction of outcome of anthracycline treatment." This invention relates to methods for predicting the outcome of anthracycline treatment in patients with cell proliferative disorders. It involves determining the expression level of specific genes, including PITX2, TFF1, and PLAU. Additionally, he has developed methods for the prognosis of breast cancer, which includes modified genomic sequences and oligonucleotides for detecting the cytosine methylation state of genomic DNA. This method aims to predict disease-free survival and response to endocrine treatment in patients with breast tissue disorders.
Career Highlights
Throughout his career, John W Martens has worked with several prominent companies, including Epigenomics AG and Therawis Diagnostics GmbH. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in cancer treatment.
Collaborations
John has collaborated with esteemed colleagues in the field, including John Foekens and Nadia Harbeck. These partnerships have further enriched his research and development efforts.
Conclusion
John W Martens is a distinguished inventor whose work in cancer treatment prediction is paving the way for improved patient outcomes. His innovative patents and collaborations highlight his commitment to advancing medical science.